MitraClip for the treatment of heart failure with mitral regurgitation: A cost-effectiveness analysis in a Chinese setting
BackgroundHeart failure (HF) with mitral regurgitation is associated with decreased survival. Guideline-directed medical therapy and transcatheter edge-to-edge repair (TEER) are the main options for HF patients with severe mitral regurgitation who are considered high-risk or prohibitive. To date, th...
Main Authors: | Wengang Xia, Kangning Han, Yake Lou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.970118/full |
Similar Items
-
Critical evaluation of the MitraClip system in the management of mitral regurgitation
by: Deuschl F, et al.
Published: (2016-01-01) -
Percutaneous Mitral Valve Repair with the MitraClip System in the Current Clinical Practice
by: Sergio Sorrentino, et al.
Published: (2021-01-01) -
MitraClip After Failed Surgical Mitral Valve Repair—An International Multicenter Study
by: Zouhair Rahhab, et al.
Published: (2021-04-01) -
What Can We Expect From MitraClip After Failed Surgical Mitral Repair?
by: Donald Glower
Published: (2021-04-01) -
Cirugía tras implante fallido del dispositivo MitraClip®
by: Gertrudis Parody Cuerda, et al.
Published: (2020-09-01)